PTC Therapeutics (PTCT) Reiterated Buy at Wedbush
Tweet Send to a Friend
Wedbush maintained an Outperform on PTC Therapeutics (NASDAQ: PTCT) with a price target of $55.00. Analyst Christopher N. Marai thinks ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE